Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%
Information source: Tehran University of Medical Sciences
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Diltiazem (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Tehran University of Medical Sciences Official(s) and/or principal investigator(s):
Farshad Jalili, Resident, Principal Investigator, Affiliation: Sina Hospital
Summary
The purpose of this study is to evaluate the effectiveness of diltiazem ointment 2 percent
in reducing pain after hemorrhoidectomy.
Clinical Details
Official title: Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Primary outcome: Reduction of Pain
Detailed description:
Pain after hemorrhoidectomy remains a major postsurgical complication. Therefore pain
management in patients is an important goal. Many studies have focused on surgical
techniques,preoperative and postoperative regimes. We assessed a randomised double blind
placebo-controlled trial to evaluate the effect of diltiazem ointment after surgery.
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with grade 3 or 4 hemorrhoid who underwent Milligan-Morgan surgery.
Exclusion Criteria:
- Patients with a history of heart disease, blood pressure, orthostatic hypertension,
hemorrhoidal surgery,or those who had previous adverse effect from calcium channel
blocker drugs and also those who were pregnant.
Locations and Contacts
Sina General Hospital, Tehran, Iran, Islamic Republic of
Additional Information
Starting date: October 2007
Last updated: May 2, 2009
|
